Phase II study of Ccr-based dose-control of S-1 in the first-line chemotherapy of S-1/oxaliplatin(SOX)+bevacizumab regimen for advanced colorectal cancer
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Interventions: Ccr-based dose-control of S-1 in the first-line chemotherapy of S-1/oxaliplatin(SOX)+bevacizumab regimen Primary outcome(s): Adverse events Study Design: Single arm Non-randomized
创建时间：
2014-10-15
